Recombinant CD28 (CytoMed)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant CD28 (CytoMed)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionT-cell-specific surface glycoprotein CD28 agonists
TargetsT-cell-specific surface glycoprotein CD28
Therapy Area/IndicationsRejection of organ transplantationHypersensitivityAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCytomed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytomed
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationHypersensitivityAutoimmune Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A